SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-014148
Filing Date
2021-03-18
Accepted
2021-03-18 16:06:08
Documents
59
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20201231.htm 10-K 2250444
2 EX-23.1 abio-ex231_7.htm EX-23.1 3045
3 EX-31.1 abio-ex311_10.htm EX-31.1 18814
4 EX-31.2 abio-ex312_9.htm EX-31.2 18897
5 EX-32.1 abio-ex321_6.htm EX-32.1 10080
6 GRAPHIC ghsu0sjs5li5000001.jpg GRAPHIC 663
  Complete submission text file 0001564590-21-014148.txt   5691236

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abio-20201231.xml EX-101.INS 835970
8 XBRL TAXONOMY EXTENSION SCHEMA abio-20201231.xsd EX-101.SCH 37875
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20201231_cal.xml EX-101.CAL 43111
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20201231_def.xml EX-101.DEF 107921
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20201231_lab.xml EX-101.LAB 369793
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20201231_pre.xml EX-101.PRE 256125
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 21754388
SIC: 2835 In Vitro & In Vivo Diagnostic Substances